A. Andalib Et Al. , "The Upregulation of hsa-mir-181b-1 and Downregulation of Its Target CYLD in the Late-Stage of Tumor Progression of Breast Cancer," Indian Journal of Clinical Biochemistry , vol.35, no.3, pp.312-321, 2020
Andalib, A. Et Al. 2020. The Upregulation of hsa-mir-181b-1 and Downregulation of Its Target CYLD in the Late-Stage of Tumor Progression of Breast Cancer. Indian Journal of Clinical Biochemistry , vol.35, no.3 , 312-321.
Andalib, A., Rashed, S., Dehbashi, M., Hajati, J., Noorbakhsh, F., & Ganjalikhani-Hakemi, M., (2020). The Upregulation of hsa-mir-181b-1 and Downregulation of Its Target CYLD in the Late-Stage of Tumor Progression of Breast Cancer. Indian Journal of Clinical Biochemistry , vol.35, no.3, 312-321.
Andalib, Alireza Et Al. "The Upregulation of hsa-mir-181b-1 and Downregulation of Its Target CYLD in the Late-Stage of Tumor Progression of Breast Cancer," Indian Journal of Clinical Biochemistry , vol.35, no.3, 312-321, 2020
Andalib, Alireza Et Al. "The Upregulation of hsa-mir-181b-1 and Downregulation of Its Target CYLD in the Late-Stage of Tumor Progression of Breast Cancer." Indian Journal of Clinical Biochemistry , vol.35, no.3, pp.312-321, 2020
Andalib, A. Et Al. (2020) . "The Upregulation of hsa-mir-181b-1 and Downregulation of Its Target CYLD in the Late-Stage of Tumor Progression of Breast Cancer." Indian Journal of Clinical Biochemistry , vol.35, no.3, pp.312-321.
@article{article, author={Alireza Andalib Et Al. }, title={The Upregulation of hsa-mir-181b-1 and Downregulation of Its Target CYLD in the Late-Stage of Tumor Progression of Breast Cancer}, journal={Indian Journal of Clinical Biochemistry}, year=2020, pages={312-321} }